Pritchard J, Broadbent V
Department of Haematology/Oncology, Hospital for Sick Children, London, England.
Br J Cancer Suppl. 1994 Sep;23:S1-3.
The Histiocytoses are a group of rare and puzzling multisystem disorders, currently regarded as non-malignant but often treated with 'cancer chemotherapy'. In this article, the origins of histiocytes and of the Histiocyte Society's classification of the Histiocytoses are described with suggested minor modifications to the classification. The current nomenclature for the 2 principal diseases, now named 'Langerhans cell histiocytosis' and 'Haemophagocytic Lymphohistiocytosis', is less confusing than the terms originally chosen. The article sets the scene for the succeeding papers, which focus on 'Langerhans cell histiocytosis'.
组织细胞增多症是一组罕见且令人困惑的多系统疾病,目前被视为非恶性疾病,但常采用“癌症化疗”进行治疗。在本文中,描述了组织细胞的起源以及组织细胞协会对组织细胞增多症的分类,并建议对该分类进行一些小的修改。目前这两种主要疾病的命名,即现在所称的“朗格汉斯细胞组织细胞增多症”和“噬血细胞性淋巴组织细胞增多症”,比最初选用的术语更不易混淆。本文为后续聚焦于“朗格汉斯细胞组织细胞增多症”的论文奠定了基础。